Fund
Logos Capital
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 2
- Lead
- 0
- New entries
- 2
- Follow ons
- 0
- Latest operation
- 7 April 2026
- Sectors
- Diagnostics, Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 07 Apr | United States, Diagnostics | Series B | 97 M$ | Participant |
| 06 Feb | United States, Biotech | Series D and later | 130 M$ | Participant |
Co investors 21 funds crossed
- Ascenta Capital 1 operation
- Bain Capital Life Sciences 1 operation
- BlackRock 1 operation
- BVF Partners 1 operation
- Casdin Capital 1 operation
- Catalio Capital Management 1 operation
- Frazier Life Sciences 1 operation
- General Catalyst 1 operation
- GV 1 operation
- Hillhouse Investment 1 operation
- Indicator Ventures 1 operation
- Innoviva 1 operation
- JSL Health 1 operation
- Kicker Ventures 1 operation
- OrbiMed 1 operation
- Palo Santo VC 1 operation
- RA Capital Management 1 operation
- S32 1 operation
- Samsung Next 1 operation
- Venrock Healthcare Capital Partners 1 operation
- Wellington Management 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.